Targeting Inflammatory & Fibrotic Pathways in SSc-ILD
Faculty:
Fernando Jose Martinez, MD, MS
Bruce Webster Professor of Internal Medicine
Chief, Division of Pulmonary and Critical Care Medicine
Weill Cornell Medicine
New York, NY
Elizabeth R. Volkmann, MD, MS
Assistant Professor of Medicine
Director, UCLA Scleroderma Program
Co-Director, UCLA CTD-ILD Program
Division of Rheumatology
Department of Medicine
University of California, Los Angeles
David Geffen School of Medicine
Los Angeles, CA
Description:
After completing this activity, the participant should be better able to:
- Outline risk factors for progressive SSc-ILD
- Assess recommended monitoring for patients with scleroderma and SSc-ILD
- Select appropriate, evidence-based therapy for patients who have SSc-ILD
This activity is provided by Paradigm Medical Communications, LLC in collaboration with the Pulmonary Fibrosis Foundation.
This activity is supported by an educational grant from Genentech, a member of the Roche Group.